跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 3,848 条关于
“absence epilepsy”
全部
3,848
临床试验
2,349
药物
36
机构
14
资讯
1,449
2年前
Bright Minds Biosciences Advances BMB-101 for Drug-Resistant Epilepsy in Phase 2 Trial
2年前
Bright Minds Biosciences Initiates Phase 2 Trial of BMB-101 for Drug-Resistant Epilepsies
去年
Bright Minds Biosciences Appoints Stephen Collins as Chief Medical Officer to Advance CNS Therapies
去年
Piper Sandler Initiates Buy Rating on Bright Minds' BMB-101 for Drug-Resistant Epilepsy Treatment
去年
Bright Minds Biosciences Appoints Stephen Collins as Chief Medical Officer to Advance Epilepsy Therapies
去年
Lundbeck's Bexicaserin Shows Sustained 59% Seizure Reduction in Rare Epilepsy Extension Study
9个月前
Bright Minds Biosciences Raises $175 Million to Advance Epilepsy Drug BMB-101 Through Phase II Trials
9个月前
FDA Approves Reformulated Ranitidine After Five-Year Market Absence Due to Carcinogen Concerns
去年
Gedeon Richter Reintroduces Dydrogesterone-Only HRT Option to UK Market After 17-Year Absence
8个月前
Bright Minds Biosciences Set to Release Phase 2 Results for BMB-101 in Drug-Resistant Epilepsy
第 1 页,共 145 页
上一页
下一页